You are here: Home » Companies » News
Business Standard

EU ban stays on Ranbaxy's two plants

Press Trust Of India  |  New Delhi 

Exports from plants at Toansa and Dewas to Europe will remain suspended as probes are continuing, even as Indian authorities have withdrawn the certification of manufacturing standards from one of the units, European health regulator EMA said on Wednesday.

The (EMA) said Indian authorities had withdrawn certification to the Toansa plant, while an international inspection of the Dewas plant is been planned for June.



"EMA and national medicines authorities in the EU are progressing with their assessment of reports of non-compliance with Good Manufacturing Practice at two Laboratories' sites in India," an EMA spokesperson said.

RECOMMENDED FOR YOU

EU ban stays on Ranbaxy's two plants

Exports from Ranbaxy plants at Toansa and Dewas to Europe will remain suspended as probes are continuing, even as Indian authorities have withdrawn the certification of manufacturing standards from one of the units, European health regulator EMA said on Wednesday.The European Medicines Agency (EMA) said Indian authorities had withdrawn certification to the Toansa plant, while an international inspection of the Dewas plant is been planned for June."EMA and national medicines authorities in the EU are progressing with their assessment of reports of non-compliance with Good Manufacturing Practice at two Ranbaxy Laboratories' sites in India," an EMA spokesperson said. Exports from plants at Toansa and Dewas to Europe will remain suspended as probes are continuing, even as Indian authorities have withdrawn the certification of manufacturing standards from one of the units, European health regulator EMA said on Wednesday.

The (EMA) said Indian authorities had withdrawn certification to the Toansa plant, while an international inspection of the Dewas plant is been planned for June.

"EMA and national medicines authorities in the EU are progressing with their assessment of reports of non-compliance with Good Manufacturing Practice at two Laboratories' sites in India," an EMA spokesperson said.
image
Business Standard
177 22

EU ban stays on Ranbaxy's two plants

Exports from plants at Toansa and Dewas to Europe will remain suspended as probes are continuing, even as Indian authorities have withdrawn the certification of manufacturing standards from one of the units, European health regulator EMA said on Wednesday.

The (EMA) said Indian authorities had withdrawn certification to the Toansa plant, while an international inspection of the Dewas plant is been planned for June.

"EMA and national medicines authorities in the EU are progressing with their assessment of reports of non-compliance with Good Manufacturing Practice at two Laboratories' sites in India," an EMA spokesperson said.

image
Business Standard
177 22